Sources

5 Total Sources

GLP-1 Drugs Cut Obesity-Related Cancer Risk 41% in 229,000 Non-Diabetic US Adults

Medical Dialogues19h ago

GLP-1 RAs Linked to 41% Lower Obesity-Related Cancer Risk in Obese Non-Diabetic Adults

Medical Daily19h ago

GLP-1 Drugs Show Broad Systemic Effects: Cancer, Behavior, Bone, Activity Findings

mindandmatter.substack.com21h ago

GLP-1s & Novel Peptides in Obesity, Diabetes & Metabolic Health | Katrin Svensson | Episode 298

oaepublish.com17h ago

Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives

sciencedirect.com19h ago

NLRP3 inflammasome as a central target for the pleiotropic effects of GLP-1 receptor agonists - ScienceDirect